Marshall Financial Group (Maryland)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $217K | Sell |
|
|||||
|
2025
Q2 | $273K | Sell |
|
|||||
|
2025
Q1 | $341K | Sell |
|
|||||
|
2024
Q4 | $541K | Sell |
|
|||||
|
2024
Q3 | $1.61M | Hold |
|
|||||
|
2024
Q2 | $1.93M | Sell |
|
|||||
|
2024
Q1 | $1.79M | Buy |
|
|||||
|
2023
Q4 | $1.37M | Sell |
|
|||||
|
2023
Q3 | $1.26M | Sell |
|
|||||
|
2023
Q2 | $1.14M | Buy |
|
|||||
|
2023
Q1 | $1.11M | Sell |
|
|||||
|
2022
Q4 | $1.35M | Sell |
|
|||||
|
2022
Q3 | $1M | Sell |
|
|||||
|
2022
Q2 | $1.13M | Sell |
|
|||||
|
2022
Q1 | $1.36M | Buy |
|
|||||
|
2021
Q4 | $1.37M | Sell |
|
|||||
|
2021
Q3 | $1.31M | Buy |
|
|||||
|
2021
Q2 | $1.11M | Sell |
|
|||||
|
2021
Q1 | $986K | Buy |
|
|||||
|
2020
Q4 | $966K | Buy |
|